Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4053-4062

  Estable, Mario Clemente ^a,b   Bell, Brendan ^a   Merzouki, Abderrazzak ^c   Montaner, Julio S G ^b   O'Shaughnessy, Michael V ^a,b   Sadowski, Ivan J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; STRAIN DIFFERENCE; TATA BOX; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029949812     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.4053-4062.1996     Document Type: Article

References (64)

1. Ait-Khaled, M., and V. C. Emery. 1994. Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in lymph node and peripheral blood of three HIV-1 infected individuals. J. Gen. Virol. 75:1615-1621.
2. Ait-Khaled, M., J. E. McLaughlin, M. A. Johnson, and V. C. Emery. 1995. Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissue of an AIDS patient. AIDS 9:675-683.
3. Alcami, J., T. L. D. Lera, L. Folguiera, M. A. Pedraza, J. M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Ha;, D. Harrich, R. B. Gaynor, J. L. Virelizier, and F. Arezana-Seisdedos. 1995. Absolute dependance on KB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
4. Bell, B., and I. J. Sadowski. Ras responsiveness of the HIV-1 LTR requires the RBF-1 and RBF-2 binding sites. Submitted for publication.
5. Berkhout, B., and K.-T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
6. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
7. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
8. Craib, K. J. P., and M. T. Schechter. 1992. The Vancouver lymphadenopathy-AIDS study: an overview of research into HIV/AIDS. B C Med. J. 34:162-240.
9. d'Adda di Fagana, F., G. Marzio, M. I. Gutierrez, L. Y. Rang, A. Falaschi, and M. Giacca. 1995. Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 69:2765-2775.
10. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:225-231.
11. Delassus, S., A. Meyerhans, R. Cheynier, and S. Wain-Hobson. 1992. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology 188:811-8.
12. Dynan, W. S., and R. Tijan. 1983. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 32:669-680.
13. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of T lymphocytes and macrophages during the incubation period of AIDS. Nature (London) 362:359-362.
14. Englund, G., M. D. Hoggan, T. S. Theodore, and M. A. Martin. 1991. A novel HIV-1 isolate containing alterations affecting the NF-kappa B element. Virology 181:150-157.
15. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
16. Garcia, J. A., and R. B. Gaynor. 1994. Regulatory mechanisms involved in the control of HIV-1 gene expression. AIDS 8:S3-S17.
17. Garcia, J. A., F. K. Wu, R. Mitsuyasu, and R. Gaynor. 1987. Interaction of cellular proteins involved in the regulation of the human immunodeficiency virus. EMBO J. 6:3761-3770.
18. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
19. Golub, E. I., G. Li, and D. J. Volsky. 1990. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J. Virol. 64:3654-3660.
20. Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41:885-897.
21. Gunther, C. V., and B. J. Graves. 1994. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 14:7569-7580.
22. Harrich, D., C. Hsu, E. Race, and R. B. Gaynor. 1994. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:5899-5910.
23. Holzmeister, J., B. Ludewig, G. Pauli, and D. Simon. 1993. Sequence specific binding of the transcription factor c-ets1 to the human immunodeficiency virus type 1 long terminal repeat. Biochem. Biophys. Res. Commun. 197:1229-1233.
24. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837-848.
25. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
26. Kadonaga, J. T., K. R. Camer, F. R. Masiarz, and R. Tijan. 1987. Isolation of a cDNA encoding transcription factor Spl and functional analysis of the DNA binding domain. Cell 51:1079-1090.
27. Kim, J. Y. H., F. Gonzales-Scarano, S. L. Zeichuer, and J. C. Alwine. 1993. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J. Virol. 67:1658-1662.
28. Koken, S. C., J. L. B. V. Wamel, J. Goudsmit, B. Berkhout, and J. L. M. C. Geelen. 1992. Natural variant of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968-972.
29. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
30. Leprince, D., A. Gegonne, J. Coll, C. D. Taisne, A. Schneeberger, C. Lagrou, and D. Stehelin. 1983. A putative second cell-derived oncogcne of the avian leukaemia retrovirus E26. Nature (London) 306:395-397.
31. Li, Y., J. Ross, J. A. Scheppler, and J. B. R. Franza. 1991. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Mol. Cell. Biol. 11:1883-1893.
32. Lu, X., T. M. Welsh, and B. M. Peterlin. 1993. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67:1752-1760.
33. Lu, Y., N. Touzjian, M. Stenzel, T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. The NF-κB independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. J. Acquired Immune Defic. Syndr. 4:173-177.
34. Majello, B., P. DeLuca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
35. Masuda, E. S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K.-L Arai, and N. Arai. 1995. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15:2697-2706.
36. McNearney, T., Z. Hornickova, A Templeton, A. Birdwell, M. Arens, R. Markham, A. Saah, and L. Ratner. 1995. Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. Virology 208:388-398.
37. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
38. Michael, N. L., L. D'Arcy, P. K. Ehrenberg, and R. R. Redfield. 1994. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J. Virol. 68:3163-3174.
39. Molitor, J. A., W. H. Walker, S. Doerre, D. W. Ballard, and W. C. Greene. 1990. NF-KB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc. Natl. Acad. Sci. USA 87:10028-10032.
40. Myers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS. Los Alamos National Library, Los Alamos, N.Mex.
41. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
42. National Institutes of Health. 1995. AIDS research and reference reagent program catalog. National Institutes of Health publication no. 95-1536. National Institutes of Health, Bethesda, Md.
43. Olsen, H. S., and C. A. Rosen. 1992. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597.
44. Ou, S.-H. I., L. F. García-Martinez, E. J. Paulssen, and R. B. Gaynor. 1994. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J. Virol. 68:7188-7199.
45. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenslein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
46. Phares, W., and W. Herr. 1991. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 κB proto-enhancers. J. Virol. 65:2200-2210.
47. Ramsey, C. A., and A. T. Panganiban. 1993. Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J. Virol. 67:4114-4121.
48. Roy, S., U. Delling, C. H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for TAT binding and TAT-mediated trans-activation. Genes Dev. 4:1365-1373.
49. Sakaguchi, M., B. Zenzie-Gregory, J. E. Groopman, S. T. Smale, and S. Kim. 1991. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery. J. Virol. 65:5448-5456.
50. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
51. Seth, A., D. R. Hodge, D. M. Thompson, L. Robinson, A. Panayiotakis, D. K. Watson, and T. Papas. 1993. ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res. Hum. Retroviruses 9:1017-1023.
52. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
53. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104.
54. Sodroski, J. G., C. A. Rosen, F. Wong-Staal, S. Z. Salahuddin, M. Popovic, S. Arya, and R. C. Gallo. 1985. Trans acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 227:171-173.
55. Starcich, B., L. Ratner, S. F. Josephs, T. Okamoto, R. C. Gallo, and F. Wong-Staal. 1985. Characterization of long terminal repeat sequences of HTLV-III. Science 277:538-540.
56. Thiesen, H.-J., and C. Bach. 1990. Target detection assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. Nucleic Acids Res. 18:3203-3209.
57. Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid specific protein, with a HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev. 5:880-894.
58. Verdin, E., J. Paras, and C. V. Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1. EMBO J. 12:3249-3259.
59. Wasylyk, B., S. L. Hahan, and A. Giovane. 1993. The Els family of transcription factors. Eur. J. Biochem. 211:7-18.
60. Waterman, M. L., W. H. Fischer, and K. A. Jones. 1991. A thymus-specific member of the HMG protein family regulates the human T cell receptor Cα enhancer. Genes Dev. 5:656-669.
61. Waterman, M. L., and K. A. Jones. 1990. Purification of TCF-1α, a T-cell-specific transcription factor that activates the T-cell receptor Cα gene enhancer in a context-dependent manner. New Biol. 2:621-636.
62. Wobbe, C. R., and K. Struhl. 1990. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro. Mol. Cell. Biol. 10:3859-3867.
63. Zeichner, S. L., J. Y. H. Kim, and J. C. Alwine. 1991. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeal. J. Virol. 65:2436-2444.
64. Zeichner, S. L., J. Y. H. Kim, and J. C. Alwine. 1991. Analysis of the human immunodeficiency virus long terminal repeat by in vitro transcription competition and linker scanning mutagenesis. Gene Exp. 1:15-27.